Management of Nausea and Vomiting Chemotherapy-induced in Normandy (NAVI)

Centre Francois Baclesse

Status: Completed

Conditions: Vomiting; Nausea; Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT01440465

NAVI

Details and patient eligibility

About

The objective of this study was to evaluate the various parameters involved in the occurrence of nausea / vomiting during the first cycle of chemotherapy for solid tumors or hematologic among a group of chemotherapy-naive patients, despite anti standardized-emetics protocols.

Enrollment: 300 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Aged over 18 years
• With solid tumors or hematologic in first line chemotherapy, administered intravenously,
• Able to understand the meaning of the questions
• Having given their written consent to participate in the survey.

Exclusion criteria

This does not concern patients who:

• Do not give their consent for participation
• Do not speak French
• Suffer from cognitive deficits
• Are under therapy
• Must receive a combination of radio-chemotherapy
• Present an occlusive syndrome
• Metastases (s) brain (s) clinically symptomatic (s) or radiologically proven (s) or a (of) tumor (s) brain (s)
• Have been previously treated with chemotherapy
• Present a cons-indication to corticosteroids, with anti-serotonin or NK1 receptor inhibitors
• Pregnant or breastfeeding.